ARCADIA INVESTMENT MANAGEMENT CORP/MI

Position in DYN — Dyne Therapeutics, Inc.

CIK 1016972 KALAMAZOO, MI

Position in DYN

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$896,981

-$39,454 QoQ

Shares Held

49,475

+3.3% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Mar 31, 2026

ARCADIA INVESTMENT MANAGEMENT CORP/MI holds $966,746 across 5 Biotechnology names. DYN ranks #1 (92.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DYN	Dyne Therapeutics, Inc. This page	49,475	$896,981
2	SRPT	Sarepta Therapeutics, Inc.	2,800	$60,928
3	ARWR	Arrowhead Pharmaceuticals, Inc.	100	$6,270
4	VRTX	Vertex Pharmaceuticals Inc / Ma	3	$1,339
5	RXRX	Recursion Pharmaceuticals, Inc.	400	$1,228

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$896,981	49,475	+3.3%	Shares	Sole	2026-04-22
2025-12-31	$936,435	47,875	-2.7%	Shares	Sole	2026-02-10
2025-09-30	$622,696	49,225	-10.8%	Shares	Sole	2025-10-27
2025-06-30	$525,646	55,215	+23.1%	Shares	Sole	2025-08-08
2025-03-31	$469,287	44,865	-0.2%	Shares	Sole	2025-04-30
2024-12-31	$1,058,786	44,940	+16.4%	Shares	Sole	2025-02-03
2024-09-30	$1,387,014	38,614	+9.8%	Shares	Sole	2024-10-29
2024-06-30	$1,241,325	35,175	+12.3%	Shares	Sole	2024-08-05
2024-03-31	$889,316	31,325	—	Shares	Sole	2024-04-23
No filing history on record for this holder in this stock.